v3.25.2
Variable Interest Entity (Details) - USD ($)
1 Months Ended 6 Months Ended 12 Months Ended
Dec. 30, 2021
Nov. 30, 2024
Jun. 30, 2025
Dec. 31, 2024
Dec. 31, 2023
Mar. 31, 2023
Variable Interest Entity [Line Items]            
Common stock voting rights     Each Class A share of Libra is entitled to 1 vote while each Class B share of Libra is entitled to 10 votes.      
Share of economic (in Dollars per share) $ 0.001          
Variable interest primary beneficiary (in Dollars)        
Equity investment (in Dollars)         $ 77,200  
Business Combination, Series of Individually Immaterial Business Combinations [Member]            
Variable Interest Entity [Line Items]            
Voting right percentage     31.51% 31.51%    
Business Combination, Series of Individually Immaterial Business Combinations [Member] | Scipio [Member]            
Variable Interest Entity [Line Items]            
Voting right percentage     48.36%      
Business Combination, Series of Individually Immaterial Business Combinations [Member] | Mios [Member]            
Variable Interest Entity [Line Items]            
Voting right percentage     48.39%      
Libra [Member]            
Variable Interest Entity [Line Items]            
Voting right percentage       48.33%    
Mios [Member]            
Variable Interest Entity [Line Items]            
Voting right percentage       48.39%    
Scipio [Member]            
Variable Interest Entity [Line Items]            
Voting right percentage       48.36%    
Variable Interest Entity [Member]            
Variable Interest Entity [Line Items]            
Other Liabilities (in Dollars)     $ 0 $ 0    
Equity investment (in Dollars)          
Class A Ordinary Shares [Member]            
Variable Interest Entity [Line Items]            
Common stock voting rights 1   one one    
Share of economic (in Dollars per share) $ 1          
Ordinary shares (in Shares)     5,346,823 3,811,823 2,937,921 70,430
Class A Ordinary Shares [Member] | Scipio [Member]            
Variable Interest Entity [Line Items]            
Acquired shares (in Shares)   10,000        
Class A Ordinary Shares [Member] | Scipio [Member]            
Variable Interest Entity [Line Items]            
Ordinary shares (in Shares)   10,000        
Class B Ordinary Shares [Member]            
Variable Interest Entity [Line Items]            
Common stock voting rights 10   ten ten    
Share of economic (in Dollars per share) $ 0.001          
Ordinary shares (in Shares)     1,796,934 1,796,934 2,243,776  
Class B Ordinary Shares [Member] | Scipio [Member]            
Variable Interest Entity [Line Items]            
Ordinary shares (in Shares)   5,850,000        
Class B Ordinary Shares [Member] | Variable Interest Entity [Member] | Scipio [Member]            
Variable Interest Entity [Line Items]            
Acquired shares (in Shares)   5,850,000        
Libra Sciences Limited [Member]            
Variable Interest Entity [Line Items]            
Common stock voting rights     each Class A ordinary share is entitled to 1 vote and 1 share of economic benefit of the respective company, while each Class B ordinary share is entitled to 10 votes      
Ownership interest percentage     97.27% 97.27%    
Libra Sciences Limited [Member] | Group’s subsidiaries [Member]            
Variable Interest Entity [Line Items]            
Voting right percentage       31.51%    
Voting right percentage     31.51%      
Libra Sciences Limited [Member] | Business Combination, Series of Individually Immaterial Business Combinations [Member]            
Variable Interest Entity [Line Items]            
Voting right percentage     48.33%      
Mios Pharmaceuticals Limited [Member]            
Variable Interest Entity [Line Items]            
Ownership interest percentage     97.93% 97.93%    
Mios Pharmaceuticals Limited [Member] | Group’s subsidiaries [Member]            
Variable Interest Entity [Line Items]            
Voting right percentage       36.17%    
Voting right percentage     36.17%      
Scipio Life Sciences Limited [Member]            
Variable Interest Entity [Line Items]            
Ownership interest percentage     97.93% 97.93%    
Scipio Life Sciences Limited [Member] | Group’s subsidiaries [Member]            
Variable Interest Entity [Line Items]            
Voting right percentage       35.06%    
Voting right percentage     35.06%